![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » COLLEGIUM PHARMACEUTICAL ANNOUNCES THE ACHIEVEMENT OF DEVELOPMENT MILESTONE UNDER THE AGREEMENT WITH CYPRESS BIOSCIENCE
COLLEGIUM PHARMACEUTICAL ANNOUNCES THE ACHIEVEMENT OF DEVELOPMENT MILESTONE UNDER THE AGREEMENT WITH CYPRESS BIOSCIENCE
June 6, 2006
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced the achievement of a development milestone that is a subject of the Reformulation and New Product Agreement with Cypress Bioscience, Inc.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=2235391)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct